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Accepted 29 January 2017Objective:This study aimed at increasing the understanding of posttraumatic stress disorder (PTSD) in liver trans-
plant patients by describing the course of PTSD, symptomoccurrence, psychological co-morbidity, and the nature
of re-experiencing symptoms.
Methods: A prospective cohort studywas performed among 95 liver transplant recipients from before transplan-
tation up until one year post-transplantation. Respondents filled out a questionnaire regarding psychological
functioning (PTSD, anxiety, and depression) before, and at 3, 6, and 12months post-transplantation. Both quan-
titative and qualitative methods were used to analyze the data.
Results: Before transplantation, respectively 10.5% and 6.3% of the respondents were identified as possible cases
of full or partial PTSD. In all cases, co-morbid conditions of anxiety and/or depression were present. After trans-
plantation, no newonset of full PTSDwas found. Newonset of possible partial PTSDwas found in six respondents.
Arousal symptoms were the most frequently reported symptoms, but may not be distinctive for PTSD in trans-
plant patients because of the overlapwith disease- and treatment-related symptoms. Re-experiencing symptoms
before transplantation were mostly related to waiting for a donor organ and the upcoming surgery; after trans-
plantation this was related to aspects of the hospital stay.
Conclusions: In our group of liver transplant patients, PTSD symptomatologywasmore present before transplan-
tation than after transplantation. Being diagnosedwith a life-threatening disease seemed to be themain stressor.
However, when a diagnosis of PTSD is suspected, assessment by a clinician is warranted because of the overlap
with mood and anxiety disorders, and disease- and treatment-related symptoms.







Since the introductionof the fourth edition of theDiagnostic and Sta-
tistical Manual of Mental Disorders (DSM-IV) [1] in 1994, being diag-
nosed with a life-threatening illness has been introduced as a
potential stressor event for PTSD. Since then, PTSD has been described
in a variety of somatic diseases and treatments, including organ trans-
plantation [2–7]. A recent systematic review [8] showed that 0–46% of
transplant recipients had clinically relevant symptom levels of PTSD,
while clinician-ascertained PTSD was present in 1–16% of the cases.PO Box 30.001 (FC14), 9700 RBStudies on transplant candidates are limited and mainly retrospective
in nature, showing that clinically relevant symptom levels of PTSD
were present in 7–25% [9,10], while 2–6% of transplant candidates satis-
fied the criteria for PTSD [11,12].
So far, the focus of the studies on PTSD after organ transplantation
has mainly been on assessing prevalence rates, identifying risk factors,
and the impact on outcomes after transplantation. Little attention has
beenpaid towhich aspects of the transplant process are traumatic in na-
ture, to the occurrence of specific symptoms of PTSD, and to the overlap
of PTSD symptomswith disease symptoms and other psychological dis-
orders. Besides this, prospective studies examining the course of PTSD in
the same patient group before and after transplantation are lacking.
Examining these aspects may help to gain a better understanding of
the concept of PTSD in the transplant population.
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and arousal [1]. Symptoms of re-experiencing, such as recurrent
dreams, intrusive memories, or flashbacks related to the event, are
seen as the core symptom of PTSD [13]. However, contrary to other
stressful events that may lead to PTSD, such as rape or car accidents,
being diagnosed with a life-threatening illness is not a single event
but a process, comprising a number of stressors that may lead to a trau-
matic experience. In the liver transplant process these are, among
others, being diagnosed with a potentially life-ending disease, for
which a donor organ is needed to survive, but where it is uncertain if
this donor organ will arrive in time. Each year approximately 15% of
transplant candidates die while on the organ transplant waiting list
[14]. When a donor organ becomes available, patients have to undergo
major surgery, followed by a stay on the intensive care unit (ICU) often
accompanied by a delirium. After a successful transplantation, patients
have to adjust to a life with a life-long regimen of immunosuppressive
drugs and life-style rules but theymay aswell have to deal with serious,
potentially life-ending, complications, such as rejection of the graft, or
the development of cardiovascular diseases or cancer [15,16]. Examin-
ing the nature of these symptoms in transplant patients may provide
valuable insight into stressors associated with PTSD in this population.
The symptom clusters of avoidance and arousal are more general in
nature, and show an overlap with mood and anxiety disorders [17].
Avoidance symptoms refer to the avoidance of distressing thoughts,
feelings, or reminders of the event, but also detachment from others,
and hopelessness about the future. Arousal symptoms are characterized
by aggressive behavior, sleep disorders, and hyper-vigilance.
An important aspect to consider regarding these PTSD symptoms is
that they should not be the result of anothermedical condition,medica-
tion, drugs, or alcohol [18]. In liver transplant patients, arousal symp-
toms like sleeping disorders and concentration problems may also be
disease- or treatment-related. Sleeping disorders are common in both
transplant candidates (35–73%) and transplant recipients (41–73%)
mainly due to hepatic encephalopathy, the underlying liver disease or
physical problems [19–23]. Concentration problems and irritability
may also interfere with symptoms of encephalopathy before transplan-
tation [24]. Therefore, examining the occurrence of PTSD symptoms, in
transplant patients can add to the understanding of PTSD in the trans-
plant population.
Because of the overlap of avoidance and arousal symptoms with
mood and anxiety disorders, examining comorbidity between PTSD,
anxiety, and depression, and the overlap of symptoms of anxiety and
depressionwith the symptom clusters of PTSDmay help to differentiate
between these problems.
The aim of this study was to increase the understanding of PTSD in
liver transplant candidates and recipients by describing the course of
PTSD from before transplantation up until the first year after transplan-
tation, symptom occurrence, the overlap of PTSD with anxiety and de-
pression, and to examine the nature of re-experiencing symptoms in
liver transplant patients.
2. Methods
A prospective cohort study on psychological aspects of liver trans-
plantation was performed among transplant patients in all three liver
transplant centers in the Netherlands. Transplant candidates who
were placed on the waiting-list between October 2009 and April 2013
were asked to participate. Inclusion criteriawere: ≥18 years, and receiv-
ing medical treatment in one of the three transplant centers. Exclusion
criteria were: unable to fill out a questionnaire due to physical, mental,
or cognitive functioning, or due to a language barrier.
Eligible transplant candidates (n=350) received a letter explaining
the purpose and procedure of the study, togetherwith an informed con-
sent form and a pre-addressed, stamped return envelope. After written
informed consent, respondents received a baseline questionnaire (T0).
Measurements of psychological functioning were repeated every sixmonths after inclusion in the study until transplantation. In this study,
data from the last measurement-point before the transplant were
used to describe PTSD symptoms before transplantation (T0). After
transplantation respondents filled out a questionnaire at three (T1),
six (T2), and twelve (T3)months after the transplant surgery. The insti-
tutional review board of the transplant center that initiated the study
approved the study, and a positive recommendation of local feasibility
was obtained from the other transplant centers (METc2009.190).2.1. Research instruments
Tomeasure symptoms of PTS, the Self-Rating Inventory for Posttrau-
matic Stress Disorder (SRIP) was used [25], a Dutch screening instru-
ment that registers symptoms of PTSD. The 22 items, corresponding to
the DSM-IV criteria for PTSD, are rated on a 4-point self-report scale
(1= not at all, to 4= extremely). The SRIP has satisfying psychometric
properties: validity (0.90), reliability (0.92), sensitivity (83%), and spec-
ificity (72%) [25]. In this study Cronbach's alphas of the SRIP were, re-
spectively, 0.89 (T0), 0.88 (T1), 0.87 (T2), and 0.87 (T3).
The items of the SRIP are stated in general terms, by referring to a
stressful experience that happened in the past. In order to be able to ex-
amine symptoms of PTSD related to the end-stage organ disease (T0) or
to the transplantation (T1-T3), the items were adjusted by replacing
“stressful event” with either “my disease” or “my transplantation.” Re-
spondents who reported having re-experiencing symptoms, such as in-
trusive thoughts or recurrent dreams, were asked to briefly describe the
nature of these re-experiencing symptoms.
In the SRIP, five of the PTSD symptomsmentioned in the DSM-IV are
split into two separate items. For example, “having difficulty falling or
staying asleep” is split into two items: “having difficulty falling asleep”
and “having difficulty staying asleep.” To correspond to the DSM-IV
criteria, SRIP items that belong to the same PTSD symptom were
merged into one item.
A cut-off score of ≥39was used to identify respondentswith clinical-
ly relevant symptom levels of PTS [26]. To be able to identify possible
cases of PTSD, all items were recoded into 0 (no symptom of PTSD,
scores 1 or 2) and 1 (symptomof PTSD, scores 3 or 4). For each symptom
cluster, the number of symptoms was calculated by adding up the
recoded symptom scores. Based on DSM-IV-criteria, possible cases of
full PTSDwere defined as the presence of one symptomof re-experienc-
ing, three avoidance symptoms, and two arousal symptoms [1]. Regard-
ingpossible cases of partial PTSD, different criteria have beenused in the
literature, either satisfying symptom clusters at two of the three symp-
tom clusters [27], or having one symptom in each symptom cluster [28].
Because intrusive re-experiencing is recognized as the core symptom of
PTSD, the latter definition of partial PTSD was used in this study.
To measure psychological co-morbidity, the symptoms of anxiety
and depression were assessed using, respectively, the short form of
the State-Trait Anxiety Inventory (STAI-6) [29] and the Center for Epi-
demiological Studies Depression Scale (CES-D) [30].
The STAI-6 consists of 6 items rated on a 4-point intensity scale (1=
not at all, to 4 = very much), resulting in a total sum score between 6
and 24. Higher scores indicate more symptoms of anxiety. Based on a
transformation of the original 20 item scale cut-off of ≥40 for the gener-
al population [31], a cut-off score of ≥12 was used to identify clinically
relevant cases. The convergent validity of the STAI-6 with the full form
of the STAI showed a correlation of 0.95 [32]. Cronbach's alpha of the
STAI-6 in the present study varied from 0.87 to 0.89 at the different
measurement-points.
The CES-D consists of 20 items, scored on a 4-point self-report scale
(0 = seldom or never, to 4 = most of the time-always). Higher scores
indicate more symptoms of depression. A cut-off score of ≥16 was
used to identify clinically relevant cases [33]. Cronbach's alpha of the
CES-D in the present study varied from 0.91 to 0.92 at the different
measurement-points.
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al level, nationality, and employment status were retrieved by self-re-
port. Clinical data regarding primary liver disease and time on
waiting-list were obtained from the medical record.
2.2. Statistical analyses
Descriptive statistics were used to calculate mean or median scores,
and prevalence rates regardingdemographic and clinical characteristics,
and prevalence and incidence rates of full and partial PTSD. Differences
between groups were analyzed using Fisher's exact test or χ2-test for
nominal variables. Because of non-normal distribution, theMann-Whit-
ney U test was used to analyze differences between groups on continu-
ous variables.
Pearson's correlation coefficient was used to examine the associa-
tion between the symptom clusters of PTSD with symptoms of anxiety
and depression.
To analyze the qualitative data regarding re-experiencing symp-
toms, content analysis was performed by two researchers (GD/CA), in-
dependent of each other. Data were examined using a direct approach
with a priori categories based on the re-experiencing symptoms in the
DSM-IV diagnostic criteria for PTSD. Consensus on the coding was
reached if the coding corresponded completely or after discussion
about the differences in coding. If no consensus was reached, a third re-
searcher (MJS) was asked to examine the specific data. Data were
discussed with all researchers involved to reach final consensus.
3. Results
3.1. Study population
Of the 350 eligible transplant candidates, 241 (69%) agreed to partic-
ipate. Of these, 116 received a transplant within the study period. How-
ever, for 21 respondents, datasets were incomplete and therefore
excluded from analyses. Reasons for missing data were: deceased
(n = 12), hospitalization at measurement-point (n = 3), lost to fol-
low-up (n= 3), questionnaire not returned (n= 2), and re-transplan-
tation (n = 1). Demographic and clinical characteristics of the totalTable 1
Demographic and clinical characteristics of the study population.
All respondents n = 116 Respondents include
n (%)
Sex: Male 76 (65.5) 63 (66.3)










































Age (at time of transplantation) 50.8 (11.4) 50.3 (11.3)
Time on waiting-list (in months) 9.4 (0.2–77.5) 9.5 (0.2–77.5)study population, and included and excluded respondents are shown
in Table 1. No significant differences were found between respondents
included or excluded from the analyses.
3.2. Prevalence and incidence rates of PTSD
Table 2 shows the prevalence rates of PTSD at the differentmeasure-
ment-points. Clinically relevant symptomatology, based on the cut-off
score (≥39), as well as possible cases of PTSD, based on criteria for full
and partial PTSD,weremore present before transplantation,when com-
pared to the period after transplantation. The cumulative incidence, the
proportion of individuals newly diagnosed with possible full or partial
PTSD before and in the first year after transplantation, was 23.2%
(Table 2). After transplantation, no new onset of full PTSD was found,
whereas new onset of possible cases of partial PTSD was found in six
transplant recipients.
3.3. Symptom occurrence
Fig. 1 provides an overview of the percentage of respondents with
clinically relevant symptoms (scores 3 or 4) of all PTSD symptoms at
the four measurement-points. Regarding re-experiencing symptoms,
“recurring dreams” and “intrusivememories”were themost frequently
reported symptoms at all measurement-points. In the avoidance symp-
tom cluster, “sense of foreshortened future” and “disinterest in activi-
ties” were the most reported symptoms before transplantation. After
transplantation, the symptom “forgot important aspects” became most
prevalent. The most reported symptoms in the arousal cluster were
“having difficulty falling or staying asleep” and “problems
concentrating.”
3.4. Psychological comorbidity
Before transplantation, almost all respondents who were identified
as possible cases for either full or partial PTSD, also showed clinically rel-
evant symptoms levels of both depression and anxiety (Fig. 2).
To identifywhich symptom clusters of PTSD showed an overlapwith



























Prevalence rates based on cut-off score (≥39), and prevalence and (cumulative) incidence rates of possible cases of full, partial, andnoPTSD, based onDSM-IV criteria before and in thefirst
year after transplantation.
N = 95 Before transplantation 3 months after transplantation 6 months after transplantation 12 months after transplantation
Point-prevalence (n/%)
Cut-off ≥39 30 (31.6) 15 (15.8) 14 (14.7) 14 (14.7)
Full PTSD 10 (10.5) 1 (1.1) 0 (0) 0 (0)
Partial PTSD 6 (6.3) 5 (5.3) 6 (6.3) 3 (3.2)
No PTSD 79 (83.2) 89 (93.6) 89 (93.6) 92 (96.8)
Incidence (n/%) Before transplantation 3 months after transplantation 6 months after transplantation 12 months after transplantation Cumulative Incidence (n/%)
Full PTSD 10 (10.5) 0 0 0 10 (10.5)
Partial PTSD 6 (6.3) 1 (1.1) 3 (3.2) 2 (2.1) 12 (12.7)
Total 16 (16.8) 1 (1.1) 3 (3.2) 2 (2.1) 22 (23.2)
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were examined. Because of the few possible cases of full and partial
PTSD in the post-transplant period, we were only able to perform
these analyses using data from the pre-transplant measurement. Re-
garding anxiety, all symptom clusters of PTSD were significantly corre-
lated with the STAI-6 total score. The strength of the correlation was
moderate for the re-experiencing cluster (r = 0.32), and large for both
the avoidance symptom cluster (r = 0.55) and the arousal symptom
cluster (r = 0.57). Regarding depression, all symptom clusters of PTSD
were also significantly correlated with the CES-D total score. The
strength of these correlations was moderate for the re-experiencing
cluster (r = 0.39), and large for both the avoidance symptom cluster
(r = 0.62) and the arousal symptom cluster (r = 0.61).
3.5. Nature of re-experiencing symptoms
Because re-experiencing symptoms are seen as the core symptom of
PTSD,wewere interested in the nature of these symptoms. Of the 95 re-
spondents, 49 (52%) described the content of their re-experiencing
symptoms at one or more of the measurement-points. Some respon-
dents mentioned the same symptoms at several measurement-points.
Symptoms were therefore merged at the individual level at two mea-
surement-points in time: before and after transplantation.
3.5.1. Symptoms of re-experiencing before transplantation
Before transplantation, intrusive thoughts related to the transplant
were reported by fourteen (15%) of the respondents. These thoughts
were mainly related to the period of waiting for an organ, such as con-
cerns about timely availability of an organ and waiting for “the call.”
One respondent experienced a failed attempt to transplant, prior to a
successful transplant, because the donor organ was rejected at the
final decision, leaving the respondent with concerns about the success
of any upcomingorganoffer. Other respondents reported that theywor-
ried about the transplantation itself. They were concerned about beingFig. 1. overview of respondents (%) with specific PTSDphysically unable to undergo a transplantation because of their deterio-
rating health status or about the success of the transplant surgery. In ad-
dition, concerns about their family were described, mostly in terms of
leaving their loved ones behind in case the transplant would not be in
time or would be unsuccessful.
Two respondents mentioned that they had recurrent dreams about
the transplantation or about death. Three respondents mentioned that
they felt distress from cues related to medical complications or to the
death of a family member with the same liver disease, leaving them
with feelings of anxiety for their own future.
3.5.2. Symptoms of re-experiencing after transplantation
After transplantation, 32 (34%) of the respondents reported one or
more re-experiencing symptoms. Twenty-one respondents reported
having intrusive memories or thoughts about the transplant, mostly re-
lated to the clinical phase after the transplantation, such as the stay on
the ICU or the nursing ward, but also regarding specific aspects of the
clinical phase, such as experiencing delirium, interventions that restrict-
ed freedomofmovement, or the feeling of being totally dependent upon
others. Besides this, fears concerning the future, for example about the
physical recovery or the possibility of graft loss, were described. Intru-
sive thoughts related to the death of the donor were also reported.
Recurrent dreams or nightmares about the transplantation were re-
ported by fourteen respondents. These dreams were mostly about as-
pects of the transplant process, such as the surgery or the ICU stay, but
unrealistic dreams were also present (e.g., being hunted by sharks, hor-
ror-like dreams). One respondent described a feeling of reliving that
consisted of a sensation of choking, which reminded of an experience
during the stay on the ICU. Distress at cues was mentioned by eight re-
spondents. These cues were related to medical complications, such as
recurrence of liver disease or signs of rejection, but also sounds or situ-
ations that reminded them of the hospital stay. Only one respondent re-
ported physiological reactions to cues. This respondent felt nausea
when confronted with reminders of the hospital stay.symptoms at the different measurement-points.
Fig. 2. Percentage of respondents with possible cases of full or partial PTSD and
comorbidity of anxiety and/or depression before transplantation.
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The results of this study showed that in our population of liver trans-
plant patients clinically relevant PTS symptomatology was more pres-
ent than possible cases of either full or partial PTSD, and that both
PTSD symptomatology and possible cases were more prevalent before
than in the first year after transplantation. Remarkably, we found no
newonset of full PTSD andonly a fewpossible cases of newonset of par-
tial PTSD after transplantation. All respondents who were identified as
possible cases of either partial or full PTSD before transplantation also
showed clinically relevant symptom levels of anxiety and/or depression.
Regarding symptom occurrence, arousal symptomsweremost pres-
ent at all measurement-points, especially sleeping disorders and con-
centration problems.
Our qualitative data showed that in our study population symptoms
of re-experiencing before transplantation were mainly related to the
wait for a suitable donor and the upcoming transplant surgery; after
transplantation mainly to the clinical phase after the transplant surgery
and concerns about the future.
Ourfindings regardingprevalence rates are in linewith other studies
that show that PTSD symptomatology is higher than possible cases of
PTSD in patients after medical illness and treatment [34], and after
liver transplantation [27,35]. However, we found more possible cases
of PTSD before the transplantation than previous studies among trans-
plant candidates [9,11,12].
Based on our qualitative data, the most prominent stressor for the
development of PTSD in our group of Dutch liver transplant patients
seemed to be “being diagnosed with a life-threatening disease.” The na-
ture of the re-experiencing symptoms, as described by the respondents,
showed that, before transplantation, the unpredictability of the timing
of the transplantation, along with deterioration in health status, left
transplant candidates not onlywith concerns about the timely availabil-
ity of a donor organ but also with concerns about leaving their loved
ones behind.
Symptoms of re-experiencing after the transplantation were mostly
related to the clinical phase after the transplantation (e.g., ICU stay, de-
lirium) but also represented current stressors like concerns about the
recovery, or conceived future events like fear of graft loss. Although
34% of the respondents reported having intrusive thoughts, dreams, or
distress at cues after the transplantation, this did not lead to the new
onset of full PTSD; furthermore, only 6% of the respondents were iden-
tified as possible new cases of partial PTSD. This might indicate that,
after a successful transplantation,most of the respondentswere capable
of successfully processing their transplant experience. In earlier studies
a stay on the ICU and delirium have been identified as potential risk fac-
tors for PTSD [36–39]. However, the results of our study do not support
this finding.Although arousal symptomsweremost present at all measurement-
points, the presence of arousal symptomsmay not be indicative of PTSD
in the liver transplant population because of the overlap with disease
and treatment-related problems and other psychological disorders.
Sleeping disorders and concentration problems are common in trans-
plant patients, mainly due to physical problems [19–23]. Therefore,
when transplant patients report arousal symptoms, causes other than
PTSD should be kept in mind. Moreover, we found that PTSD symptom-
atology in liver transplant patients was often accompanied by co-mor-
bid conditions of anxiety and/or depression, and that, especially,
avoidance and arousal symptoms showed strong correlations with
high symptom levels of anxiety and depression.
Due to the overlap between symptoms of PTSD with disease and
treatment-related symptoms, and with other psychological disorders,
the presence of PTSD in the transplant population could easily be
overestimated. Because it is difficult to disentangle differences between
them, a structured or semi-structured diagnostic interview by a clini-
cian is warranted to confirm the diagnosis when PTSD is suspected. In
this assessment, anxiety and depression should also be considered. Fur-
thermore, alternative diagnoses, such as an acute stress disorder should
be hold in mind, because some of the re-experiencing symptoms de-
scribed by the respondents were related to current or conceived events
(medical complications, fear of graft failure), which could be indicative
of an acute stress disorder.
4.1. Strengths and limitations
The strength of our study is the prospective, longitudinal design and
the satisfactory response rate (69%) which made it possible to follow
the course of PTSD in our patient group over time. To our knowledge,
no other studies have investigated PTSD in a transplant population
from the before transplantation up until one year after the transplanta-
tion. However, the generalizability of our results for the liver transplant
population as a whole may be limited. Due to the sample size (n= 95)
the results need to be interpreted with caution. Besides this, we could
not include transplant recipients who were transplanted soon after
placement on thewaiting list or patientswith acute liver failure because
of the prospective design. In this specific patient group, the transplanta-
tion itself may have a different impact, as shown by Guimaro and col-
leagues [40], who found high symptom levels of PTS (46%) in patients
transplanted for acute liver failure. Therefore, the course of PTSD in pa-
tients with an acute onset of their liver disease or who were on the
waiting list for a short period of time, needs to be examined in future
research.
Another limitation of our study was that, because the start of the
study was before the introduction of the DSM-5 [18], we were not
able to examine PTSD in our population based on the latest insights.
However, a study by O'Donnell and colleagues [41] showed that the
prevalence scoring under DSM-5 was not significantly different from
DSM-IV. Therefore, the results of our study may also be representative
for DSM-5 criteria.
Also, the use of only self-report to assess symptoms of PTSD can be
seen as a limitation. In future research, a clinician-ascertained diagnosis
of PTSD may have added value. Also, the nature of the re-experiencing
symptoms was only assessed by self-report. As a consequence of this,
not all respondentswho indicated having intrusivememories or dreams
described the content of these thoughts or dreams. In addition, probing
questions aimed at gaining more in-depth understanding of the nature
of the re-experiencing symptoms was not possible. For future research,
we suggest using interviews to obtain amore in-depth understanding of
these symptoms.
In conclusion, in our group of Dutch liver transplant patients PTSD
symptomatology was more present than possible cases of PTSD. Also,
more patients were identified as probable cases of either full or partial
PTSD before transplantation – often accompanied by co-morbid condi-
tions of anxiety and/or depression – than after the transplant. Therefore,
93C. Annema et al. / Journal of Psychosomatic Research 95 (2017) 88–93being diagnosed with a life-threatening disease seemed to be the main
stressor for PTSD. Although aspects related to the transplantation itself,
such as the stay on the ICU or delirium, were described as stressors after
the transplant, this did not lead to development of full or partial PTSD
after transplantation. Arousal symptoms, such as sleeping disorders
and concentration problems, were most frequently reported by trans-
plant patients, but may not be indicative of PTSD because of the overlap
with disease and treatment-related factors. Therefore, healthcare
workers should especially be aware of the possibility of PTSD when
symptoms of re-experiencing are reported by transplant patients. Con-
sidering the overlap with disease and treatment-related factors and
with other psychological disorders, it is important to refer to a clinician
when PTSD is suspected in order to confirm the diagnosis and subse-
quently initiate appropriate interventions.
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